Sign Up to like & get
recommendations!
1
Published in 2022 at "Molecular pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.1c00994
Abstract: [177Lu]Lu-Ibu-DAB-PSMA, a radioligand modified with ibuprofen as the albumin binder, showed higher accumulation in PSMA-positive tumors of mice than the clinically used [177Lu]Lu-PSMA-617 but lower retention in non-targeted tissues than previously developed albumin-binding PSMA radioligands.…
read more here.
Keywords:
radioligand;
177lu sibudab;
177lu ribudab;
psma ... See more keywords